This invention provides a
drug for combating SARS-CoV-2 and antibacterial agents, and a method for preparing the same. The method involves reacting L-
cysteine and
copper sulfate under alkaline conditions to prepare negatively charged nano-Cu2S. This nano-Cu2S reacts with the main
protease M of SARS-CoV-2. pro and
papain PL pro The nano-Cu2S binds to the main
protease M of the SARS-CoV-2
virus to inhibit
viral replication. pro and
papain PL pro The dissociation constants between the components are all less than 0.001 nM. Simultaneously, nano-Cu2S exhibits
antibacterial activity, inhibiting the proliferation of various
bacteria. The synthesis process of the drugs for combating COVID-19 and antibacterial purposes according to this invention is simple and suitable for large-scale production. Nano-Cu2S has
low toxicity and good
biosafety, and can be widely used in the coatings and disinfection fields to inhibit the spread of viruses and
bacteria.